Skip to ContentSkip to Navigation
About us Latest news News News articles

Protein engineering of pencillin acyluse for improved antibiotic synthesis

16 November 2009

PhD ceremony: S.A.W. Jager, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen

Thesis: Protein engineering of pencillin acyluse for improved antibiotic synthesis

Promotor(s): prof. D.B. Janssen

Faculty: Mathematics and Natural Sciences

 

The production of ampicillin requires the use of chlorinated solvents and costs a lot of energy. More environmental benign alternatives, such as biocatalysis, could replace this synthesis. Simon Jager constructed mutant enzymes which could very well result in a green route for the synthesis of ampicillin.

The last century life expectancy has greatly increased. This is partly due to the discovery of antibiotics, compounds that slow down the growth of bacteria or even kill micro organisms altogether. The best known antibiotic is penicillin. Because many bacteria have become resistant to penicillin, related compounds have to be found, such as ampicillin. Penicillin acylase is an enzyme that has the potential to be used in the synthesis of ampicillin and other so called β -lactam antibiotics. However, the yield is to low for industrial application. The change of penicillin acylase by means of site-directed mutagenesis and directed evolution resulted in improved mutant enzymes. With the use of directed evolution Jager constructed hybrid enzymes and the ampicillin yield was increased by 19 % using these hybrids. Moreover, some of these hybrids were capable of catalyzing the reaction faster than the wild-type enzyme. Using site-directed mutagenesis, the yields were further improved up to 60 %. These site-directed mutants also catalyzed the reaction faster than the wild-type enzyme.

 

Last modified:17 November 2015 12.59 p.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 02 July 2025

    € 30 million investment for UG spin-off Portal Biotech

    Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.

  • 01 July 2025

    ‘Give seals space’

    The Wadden Sea is constantly changing. Native animals need to be able to adapt in   order to thrive in an environment that is shaped by the tides. By conducting research on seals in the area, PhD students Margarita Méndez-Aróstegui and Beatriz...

  • 30 June 2025

    David Lentink partners international research project on animal navigation

    Prof. David Lentink is a partner in the NaviSense project awarded 54.7 million euros by the German government to research the mechanisms animals use to navigate and how these mechanisms can inspire technology.